Cell Therapeutics Inc.

News - Cell Therapeutics Inc.

Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The Lancet Oncology

2012-05-30 22:20:31

SEATTLE, May 31, 2012 /PRNewswire/ -- Cell Therapeutics, Inc.("CTI") (Nasdaq and MTA: CTIC) today announced that results from its PIX301 phase 3 clinical trial of Pixuvri® (pixantrone) have

Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs

2012-05-29 22:20:39

SEATTLE, May 30, 2012 /PRNewswire/ -- Aequus BioPharma, Inc. ("Aequus"), a majority owned subsidiary of Cell Therapeutics, Inc.

Cell Therapeutics, Inc. (CTI) to Present at Jefferies 2012 Global Healthcare Conference

2012-05-29 10:24:29

SEATTLE, May 29, 2012 /PRNewswire/ -- Cell Therapeutics, Inc.

Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago

2012-05-29 10:24:27

SEATTLE, May 29, 2012 /PRNewswire/ -- Cell Therapeutics, Inc.

Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock

2012-05-28 22:20:38

SEATTLE, May 29, 2012 /PRNewswire/ -- Cell Therapeutics, Inc.

More News (363 articles) »

News - Cell Therapeutics Inc.

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health